Preferred Label : organometallic compounds;
MeSH definition : A class of compounds of the type R-M, where a C atom is joined directly to any other
element except H, C, N, O, F, Cl, Br, I, or At. (Grant & Hackh's Chemical Dictionary,
5th ed);
MeSH synonym : metallo organic compounds; metallo-organic compounds; compounds, organometallic; compounds, metallo-organic; metalloorganic compounds; compounds, metalloorganic; Metallo-Organic Compound; Compound, Metallo-Organic; Metallo Organic Compound; Metalloorganic Compound; Compound, Metalloorganic; Organometallic Compound; Compound, Organometallic;
Wikipedia automatic translation : Organometallic chemistry;
MeSH annotation : GEN or unspecified; prefer specifics; general or unspecified; prefer specifics;
Wikipedia link : https://en.wikipedia.org/wiki/Organometallic chemistry;
Is substance : O;
Origin ID : D009942;
UMLS CUI : C0029252;
Allowable qualifiers
Currated CISMeF NLP mapping
Indexing information
Record concept(s)
Related MeSH Supplementary Concept(s)
- ((1,2,3,3a,7a-eta)-4,5,6,7-tetrahydro-4,7-methanoindenido)(N,N,N',N'-tetramethylethylenediamine)lithium [MeSH Supplementary Concept]
- (2,3,5,6,8,9,11,12-octahydro-N-(3-(1,4,7,10-tetraazacyclododec-1-yl)propyl)-1,4,7,10,13-benzopentaoxacyclopentadecin-15-amine)copper(II) [MeSH Supplementary Concept]
- (5,6-(4,5-dichlorobenzo)-3,8,11,13-tetraoxo-2,2,9,9-tetramethyl-12,12-diethyl-1,4,7,10-tetraazacyclotridecane)oxochromate(V) [MeSH Supplementary Concept]
- 1,4,7,10-tetraazacyclododecane 1,4,7,10-tetraacetic acid (ReO-acetyl(Cys(3,4,10),Phe(7),Arg(7))alpha-MSH(3-13)) [MeSH Supplementary Concept]
- 68Ga-1,4,7,10-tetraazacyclododecane 1,4,7,10-tetraacetic acid (ReO-acetyl(Cys(3,4,10),Phe(7),Arg(7))aplha-MSH(3-13)) [MeSH Supplementary Concept]
- ALF492 [MeSH Supplementary Concept]
- As-N-7a [MeSH Supplementary Concept]
- CORM-F4 [MeSH Supplementary Concept]
- CS 292 [MeSH Supplementary Concept]
- CTC 23 [MeSH Supplementary Concept]
- CTC 96 [MeSH Supplementary Concept]
- Cu(II)-dibenzo(e,k)-2,3,8,9-tetraphenyl-1,4,7,10-tetraaza-cyclododeca-1,3,7,9-tetraene [MeSH Supplementary Concept]
- CuL2Br2 [MeSH Supplementary Concept]
- EP-3600 [MeSH Supplementary Concept]
- EUK 207 [MeSH Supplementary Concept]
- EUK-134 [MeSH Supplementary Concept]
- EUK-189 [MeSH Supplementary Concept]
- EgadMe [MeSH Supplementary Concept]
- FPA-306 [MeSH Supplementary Concept]
- Fe-HBED [MeSH Supplementary Concept]
- GSK3iXV [MeSH Supplementary Concept]
- GadoTO4 [MeSH Supplementary Concept]
- Gd-MCTA [MeSH Supplementary Concept]
- Ho-FHMA [MeSH Supplementary Concept]
- JM 1226 [MeSH Supplementary Concept]
- JM 1397 [MeSH Supplementary Concept]
- JM 1796 [MeSH Supplementary Concept]
- JM 2469 [MeSH Supplementary Concept]
- JM 2820 [MeSH Supplementary Concept]
- JM 6254 [MeSH Supplementary Concept]
- KP 1339 [MeSH Supplementary Concept]
- LAB 027 [MeSH Supplementary Concept]
- LB 145 [MeSH Supplementary Concept]
- M40401 [MeSH Supplementary Concept]
- MIL-103 [MeSH Supplementary Concept]
- MOP 11 [MeSH Supplementary Concept]
- MOP 35 [MeSH Supplementary Concept]
- MP 1177 [MeSH Supplementary Concept]
- MV6401 [MeSH Supplementary Concept]
- NMS60 [MeSH Supplementary Concept]
- NOX 101 [MeSH Supplementary Concept]
- NRCS 15 [MeSH Supplementary Concept]
- PC 1038 [MeSH Supplementary Concept]
- PIND-Ru [MeSH Supplementary Concept]
- PKU-10 [MeSH Supplementary Concept]
- PM 104 [MeSH Supplementary Concept]
- PdpaMn [MeSH Supplementary Concept]
- RAPTA-T [MeSH Supplementary Concept]
- RLP068 [MeSH Supplementary Concept]
- RM175 [MeSH Supplementary Concept]
- RP 748 [MeSH Supplementary Concept]
- STAM-1 [MeSH Supplementary Concept]
- T 86 [MeSH Supplementary Concept]
- TZh 85 [MeSH Supplementary Concept]
- UiO-66 [MeSH Supplementary Concept]
- actinium 1,4,7,10,13,16-hexaazacyclohexadecane-N,N',N'',N''',N'''',N'''''-hexaacetic
acid [MeSH Supplementary Concept]
- afodial [MeSH Supplementary Concept]
- antral [MeSH Supplementary Concept]
- atsizol [MeSH Supplementary Concept]
- bis(1,4,7,10-tetraoxacyclododecane)lithium(1) bis((1,2,3,3a,7a-eta)-4,5,6,7-tetrahydro-4,7-methanoindenido)lithate(1-) [MeSH Supplementary Concept]
- ch 55G [MeSH Supplementary Concept]
- coamid [MeSH Supplementary Concept]
- feral [MeSH Supplementary Concept]
- fodomos [MeSH Supplementary Concept]
- kobazol [MeSH Supplementary Concept]
- zimplex [MeSH Supplementary Concept]
See also
Semantic type(s)
A class of compounds of the type R-M, where a C atom is joined directly to any other
element except H, C, N, O, F, Cl, Br, I, or At. (Grant & Hackh's Chemical Dictionary,
5th ed)
https://ansm.sante.fr/tableau-marr/lutecium-177lu-oxodotreotide
2025
false
false
false
France
French
lutetium Lu 177 dotatate
risk management
patients guideline
lutetium Lu 177 dotatate
infusions, intravenous
radiotherapy
radiopharmaceuticals
radiopharmaceuticals
neuroendocrine tumors
lutetium (177Lu) oxodotreotide
drug information
organometallic compounds
octreotide
octreotide
organometallic compounds
octreotide
---
http://www.has-sante.fr/portail/jcms/c_1751307/fr/les-medicaments-de-losteoporose
2023
false
true
false
France
French
bone density conservation agents
osteoporosis
treatment outcome
alendronic acid
alendronate
guidelines for drug use
zoledronic acid
administration, oral
risedronic acid
denosumab
Raloxifene Hydrochloride
strontium ranelate
strontium ranelate
teriparatide
teriparatide
spinal fractures
hip fractures
costs and cost analysis
bone density conservation agents
drug costs
bone density
risk
osteoporosis, postmenopausal
adrenal cortex hormones
osteoporosis
osteoporotic fractures
alendronic acid and colecalciferol
drugs, generic
infusions, intravenous
risedronic acid, calcium and colecalciferol, sequential
injections, subcutaneous
raloxifene
algorithms
Adrenocortical steroid therapy
corticosteroid therapy
Risedronic Acid
Denosumab
diphosphonates
imidazoles
organometallic compounds
thiophenes
Zoledronic Acid
---
https://www.has-sante.fr/jcms/p_3264401/fr/prohance-gadoteridol
2021
false
false
false
France
French
evaluation of the transparency committee
gadoteridol
gadoteridol
gadolinium
heterocyclic compounds
organometallic compounds
---
https://www.has-sante.fr/jcms/p_3180075/fr/acide-gadoterique-guerbet
2020
false
false
false
France
Gadoteric acid (substance)
drugs, generic
magnetic resonance imaging
organometallic compounds
gadolinium
contrast media
evaluation of the transparency committee
gadoteric acid
---
https://www.has-sante.fr/jcms/p_3160913/fr/gadovistauto
2020
false
false
false
France
gadobutrol
gadobutrol
contrast media
evaluation of the transparency committee
organometallic compounds
---
https://www.has-sante.fr/jcms/p_3098008/fr/gadovistauto
2019
false
false
false
France
gadobutrol
contrast media
gadobutrol
evaluation of the transparency committee
organometallic compounds
---
https://hpr-rps.hres.ca/reg-content/sommaire-motif-decision-detailTwo.php?lang=fr&linkID=SBD00433
2019
false
false
false
Canada
French
drug information
drug approval
canada
treatment outcome
lutetium Lu 177 dotatate
lutetium Lu 177 dotatate
lutetium (177Lu) oxodotreotide
radiopharmaceuticals
radiopharmaceuticals
injections, intravenous
gastro-enteropancreatic neuroendocrine tumor
adult
disease progression
organometallic compounds
octreotide
octreotide
organometallic compounds
octreotide
intestinal neoplasms
pancreatic neoplasms
stomach neoplasms
neuroendocrine tumors
---
https://www.has-sante.fr/portail/jcms/c_2869904/fr/multihance
2018
false
false
false
France
French
evaluation of the transparency committee
child
adolescent
gadobenic acid, dimeglumine salt
gadobenic acid
organometallic compounds
meglumine
---
https://ansm.sante.fr/informations-de-securite/produits-de-contraste-a-base-de-gadolinium-et-retention-de-gadolinium-dans-le-cerveau-et-dans-dautres-tissus-suspension-des-amm-de-lacide-gadopentetique-et-du-gadodiamide-utilises-en-intraveineux-restriction-de-lamm-de-lacide-gadobenique-a-li
2018
false
false
false
France
French
pharmacovigilance note
Safety-Based drug withdrawals
gadolinium
contrast media
cerebrum
gadobenic acid
gadolinium DTPA
injections, intravenous
injections, Intra-Articular
gadobenic acid
gadopentetic acid
gadodiamide
gadodiamide
organometallic compounds
meglumine
meglumine
---
https://www.has-sante.fr/portail/jcms/c_2869898/fr/prohance
https://www.has-sante.fr/portail/jcms/c_2869898/fr/prohance-gadoteridol
2018
false
false
false
France
French
evaluation of the transparency committee
guidelines for drug use
gadoteridol
diagnostic uses of chemicals
injections, intravenous
angiography
magnetic resonance imaging
adult
child
gadoteridol
insurance, health, reimbursement
gadolinium
heterocyclic compounds
organometallic compounds
---
Lutathera - lutetium (177Lu) oxodotreotide
https://www.ema.europa.eu/medicines/human/EPAR/Lutathera
2018
false
false
false
United Kingdom
French
English
neuroendocrine tumors
summary of product characteristics
package leaflet
intestinal neoplasms
radiopharmaceuticals
radiopharmaceuticals
neoplasm metastasis
lutetium Lu 177 dotatate
lutetium Lu 177 dotatate
lutetium
drug compounding
adult
infusions, intravenous
treatment outcome
lutetium (177Lu) oxodotreotide
syndication feed
drug evaluation
drug approval
europe
pregnancy
breast feeding
orphan drug production
antineoplastic agents
antineoplastic agents
gastro-enteropancreatic neuroendocrine tumor
stomach neoplasms
pancreatic neoplasms
drug interactions
product surveillance, postmarketing
drug evaluation, preclinical
organometallic compounds
octreotide
octreotide
organometallic compounds
octreotide
---
https://www.has-sante.fr/portail/jcms/c_2864194/fr/lutathera
2018
false
false
false
France
French
neuroendocrine tumors
intestinal neoplasms
radiopharmaceuticals
neoplasm metastasis
lutetium Lu 177 dotatate
lutetium
adult
infusions, intravenous
treatment outcome
lutetium (177Lu) oxodotreotide
antineoplastic agents
evaluation of the transparency committee
survival analysis
neuroendocrine tumors
intestinal neoplasms
organometallic compounds
octreotide
octreotide
---
http://www.has-sante.fr/portail/jcms/c_2049880/fr/prohance
2015
false
false
false
France
French
evaluation of the transparency committee
injections, intravenous
contrast media
gadoteridol
insurance, health, reimbursement
whole body imaging
magnetic resonance imaging
brain diseases
spinal cord diseases
spinal diseases
gadoteridol
Magnetic resonance imaging of spinal cord with contrast (procedure)
Magnetic resonance imaging of brain and brain stem (procedure)
Magnetic resonance imaging of spine with contrast (procedure)
child
adult
gadolinium
heterocyclic compounds
organometallic compounds
spinal diseases
brain diseases
spinal cord diseases
---
http://www.has-sante.fr/portail/jcms/c_2018882/fr/prohance
2015
false
false
false
France
French
evaluation of the transparency committee
injections, intravenous
contrast media
gadoteridol
insurance, health, reimbursement
whole body imaging
magnetic resonance imaging
brain diseases
spinal cord diseases
spinal diseases
gadoteridol
Magnetic resonance imaging of spinal cord with contrast (procedure)
Magnetic resonance imaging of brain and brain stem (procedure)
Magnetic resonance imaging of spine with contrast (procedure)
child
adult
gadolinium
heterocyclic compounds
organometallic compounds
brain diseases
spinal cord diseases
spinal diseases
---
https://ansm.sante.fr/tableau-atu-rtu/lutathera-370-mbq-ml-solution-pour-perfusion
2015
false
false
false
France
French
neuroendocrine tumors
summary of product characteristics
package leaflet
guidelines for drug use
intestinal neoplasms
radiopharmaceuticals
radiopharmaceuticals
neoplasm metastasis
lutetium Lu 177 dotatate
lutetium Lu 177 dotatate
lutetium
drug compounding
adult
drug evaluation
risk assessment
infusions, intravenous
treatment outcome
lutetium (177Lu) oxodotreotide
organometallic compounds
octreotide
octreotide
organometallic compounds
octreotide
---
http://www.has-sante.fr/portail/jcms/c_1769329/fr/quadramet
2014
false
false
false
France
French
evaluation of the transparency committee
samarium Sm-153 lexidronam
analgesics, non-narcotic
radioisotopes
samarium
bone neoplasms
pain
treatment outcome
infusions, intravenous
neoplasm metastasis
lung neoplasms
prostatic neoplasms
breast neoplasms
Cancer Pain
samarium Sm-153 lexidronam
organometallic compounds
organophosphorus compounds
---
http://www.has-sante.fr/portail/jcms/c_1778239/fr/dotarem
2014
true
France
French
whole body imaging
spinal cord diseases
spinal diseases
brain diseases
gadolinium
injections, intravenous
organometallic compounds
contrast media
magnetic resonance imaging
pharmaceutical solutions
insurance, health, reimbursement
gadoteric acid
evaluation of the transparency committee
spinal diseases
spinal cord diseases
brain diseases
---
http://www.has-sante.fr/portail/jcms/c_1761869/fr/protelos
2014
false
false
false
France
French
evaluation of the transparency committee
administration, oral
strontium ranelate
strontium ranelate
bone density conservation agents
osteoporosis
osteoporosis, postmenopausal
bone density conservation agents
risk assessment
strontium ranelate
osteoporotic fractures
hip fractures
spinal fractures
guidelines for drug use
organometallic compounds
thiophenes
organometallic compounds
thiophenes
---
https://reptox.cnesst.gouv.qc.ca/pages/fiche-complete.aspx?no_produit=2154&nom=Nickel+carbonyle
Canada
French
nickel
organometallic compounds
nickel carbonyl
organometallic compounds
toxicological data sheet
---
https://reptox.cnesst.gouv.qc.ca/pages/fiche-complete.aspx?no_produit=12542&nom=Butyllithium+normal
Canada
French
lithium
organometallic compounds
butyllithium
n-butyllithium
organometallic compounds
toxicological data sheet
---
https://www.ema.europa.eu/medicines/human/EPAR/OptiMARK
2012
United Kingdom
French
English
syndication feed
organometallic compounds
contrast media
organometallic compounds
drug approval
drug labeling
injections, intravenous
magnetic resonance imaging
central nervous system diseases
liver diseases
drug interactions
pregnancy
breast feeding
gadoversetamide
gadoversetamide
gadoversetamide
organometallic compounds
package leaflet
summary of product characteristics
drug evaluation
liver diseases
central nervous system diseases
---
https://reptox.cnesst.gouv.qc.ca/pages/fiche-complete.aspx?no_produit=648949&nom=Citrate+de+magnésium
Canada
French
citrates
magnesium compounds
organometallic compounds
magnesium citrate
toxicological data sheet
---
https://reptox.cnesst.gouv.qc.ca/pages/fiche-complete.aspx?no_produit=189647&nom=Subac%E9tate+de+plomb
Canada
French
organometallic compounds
lead
lead acetate, basic
toxicological data sheet
---
https://www.ema.europa.eu/medicines/human/EPAR/Quadramet
2012
United Kingdom
French
English
syndication feed
Cancer Pain Management
Cancer Pain
organometallic compounds
bone neoplasms
pregnancy
organophosphorus compounds
pain
injections, intravenous
radiopharmaceuticals
analgesics, non-narcotic
drug evaluation, preclinical
drug compounding
drug approval
drug labeling
samarium
Cancer Pain
Cancer pain
samarium Sm-153 lexidronam
samarium Sm-153 lexidronam
samarium (153sm) lexidronam
organometallic compounds
organometallic compounds
organophosphorus compounds
organophosphorus compounds
summary of product characteristics
drug evaluation
package leaflet
---
https://www.ema.europa.eu/medicines/human/EPAR/Protelos
2012
United Kingdom
English
French
syndication feed
treatment outcome
drug approval
drug labeling
administration, oral
powders
drug interactions
pregnancy
breast feeding
hip fractures
spinal fractures
aged
strontium ranelate
strontium ranelate
bone density conservation agents
bone density conservation agents
osteoporosis, postmenopausal
osteoporosis
drug evaluation
package leaflet
summary of product characteristics
organometallic compounds
thiophenes
organometallic compounds
thiophenes
---
https://www.ema.europa.eu/medicines/human/EPAR/Osseor
2012
United Kingdom
French
English
syndication feed
organometallic compounds
organometallic compounds
thiophenes
osteoporosis, postmenopausal
thiophenes
treatment outcome
drug evaluation
drug approval
drug labeling
hip fractures
spinal fractures
bone density conservation agents
bone density conservation agents
drug interactions
strontium ranelate
strontium ranelate
strontium ranelate
organometallic compounds
thiophenes
osteoporosis
drug evaluation
package leaflet
summary of product characteristics
---
http://unt-ori2.crihan.fr/unspf/2009_Lyon_Nebois_Organom%C3%A9talliques/2009_Lyon_Nebois_Organom%C3%A9talliques_Exos.pdf
2009
true
France
organometallic compounds
exercise
problems and exercises
education, pharmacy
pharmacy
---
http://unt-ori2.crihan.fr/unspf/2009_Lyon_Nebois_Organom%C3%A9talliques/2009_Lyon_Nebois_Organom%C3%A9talliques_Film/cours_organometalliques%28breeze%29/index.htm
2009
true
false
true
France
organometallic compounds
educational course
education, pharmacy
pharmacy
---
https://www.ema.europa.eu/medicines/human/EPAR/ablavar-previously-vasovist
2008
false
United Kingdom
French
English
syndication feed
gadolinium
organometallic compounds
organometallic compounds
contrast media
drug approval
drug labeling
magnetic resonance angiography
gadolinium
injections, intravenous
vascular diseases
abdomen
extremities
adult
drug interactions
breast feeding
pregnancy
drug evaluation, preclinical
gadofosveset trisodium
gadofosveset trisodium
gadofosveset
gadolinium
organometallic compounds
summary of product characteristics
package leaflet
drug evaluation
vascular diseases
---